Exploring Cereset for improving stress and anxiety symptoms
Official title: Cereset Research Exploratory Study
Run by Wake Forest University Health Sciences · NCT03777267 · Data updated 2026-11-12
This study is testing whether a new treatment called Cereset can help people aged 11 and older who are dealing with stress, anxiety, or insomnia feel better by using sounds that match their brainwaves.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | April 12, 2019 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT03777267 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 11 or older who report symptoms of stress, anxiety, or insomnia and meet specific threshold scores on self-reported inventories.
✕Probably not a fit
Patients with severe hearing impairment or those currently involved in another active intervention research study may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This exploratory study aims to evaluate the effects of Cereset Research (CR) on autonomic function in individuals experiencing stress, anxiety, or insomnia. Participants aged 11 and older will receive between 6 and 12 sessions of CR, which involves listening to audible tones that reflect their brainwave activity. The study will assess physiological outcomes such as blood pressure and heart rate variability, alongside self-reported symptom inventories. Additionally, it will explore the impact of medications and co-morbid conditions on the outcomes of CR.
Why it matters
Potential benefit: If successful, this study could provide a novel non-invasive approach to alleviate symptoms of stress, anxiety, and insomnia.
How similar studies have gone: While the approach of using neurotechnology for autonomic regulation is innovative, similar studies have shown promise in addressing stress and anxiety through various non-invasive methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached * Subjects experiencing symptoms of stress, anxiety, or insomnia, who meet threshold scores on one or more self-reported inventories for the same. This includes the Insomnia Severity Index (ISI, ≥ 8), the Perceived Stress Index (PSS, ≥ 14), or the Generalized Anxiety Disorder 7-item (GAD-7, ≥ 5) scale. Exclusion Criteria: * Unable, unwilling, or incompetent to provide informed consent/assent. * Physically unable to come to the study visits, or to sit comfortably in a chair for up to 1.5 hours. * Severe hearing impairment (because the subject will be using ear buds during CR). * Weight is over the chair limit (285 pounds). * Currently in another active intervention research study. * Prior use of HIRREM, Brainwave Optimization, Cereset, or a wearable configuration of the same (B2, or B2v2) within the last 3 years. * Prior use of electroconvulsive therapy (ECT). * Prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, neurofeedback, biofeedback, or deep brain stimulation (DBS) within one month before enrollment. * Known seizure disorder.
Where it's running
-
Wake Forest University Health Scienc\ess
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Charles Tegeler, MD — Wake Forest University Health Sciences
- Study coordinator: Kenzie Brown
- Email: BBRP@wakehealth.edu
- Phone: 336-716-9447
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Semi-solid foods and swallowing gels to help people who have trouble swallowing pills.
This project will test whether taking medications with semi-solid formulations or a commercial swallowing gel helps adults with dysphagia and healthy volunteers swallow pills more safely.
-
Natural history of type I interferonopathies in a European patient group
This project will follow people with genetically confirmed type I interferonopathies across European centers to see how the disease develops and which clinical and blood markers track disease activity.
-
Observing the natural history of mitochondrial diseases
This study is tracking 400 people with mitochondrial diseases and 100 healthy individuals over 10 years to see how the disease affects them and to help improve future diagnosis and treatment.
-
Using Transcranial Magnetic Stimulation to Treat Neuropathic Pain in Spinal Cord Injury Patients
This study is testing whether a type of brain stimulation called rTMS can help reduce neuropathic pain in people with spinal cord injuries.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
-
Collection and storage of human biological samples for research
This study is about collecting and storing biological samples from people with different health conditions to help researchers find better ways to prevent, diagnose, and treat diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.